HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Produ...(Sigma-Aldrich and Supelco are registered...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008
Date:4/8/2009
>Sigma-Aldrich and Supelco are registered trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.
'/>"/>
| SOURCE Sigma-Aldrich Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
Breaking Biology Technology:Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6
[0] Brooks Instrument Appoints Mike Bayda as Global Level Product Manager [0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
Other Biology Technology:Evotec Expands Collaboration With InterMune 2Evotec Expands Collaboration With InterMune 3Gladstone scientists identify role of tiny RNAs in controlling stem cell fate 2Cellular construction methods emulated 2
Breaking Biology News(10 mins):University of California, San Francisco, researcher receives ASBMB-Merck Award 2Vermicompost from pig manure grows healthy hibiscus 2Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 1Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 2Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 3Continued Uptake of TNF Alpha Inhibitors and Interleukin Inhibitors Will Drive 242 2 Billion Growth in the Psoriasis Drug Market 14589 1Continued Uptake of TNF Alpha Inhibitors and Interleukin Inhibitors Will Drive 242 2 Billion Growth in the Psoriasis Drug Market 14589 2Cardio Vascular Medical Device Sends Update to Shareholders 5689 1Cardio Vascular Medical Device Sends Update to Shareholders 5689 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |